Trinity Biotech plc reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was USD 56.83 million compared to USD 62.52 million a year ago. Net loss was USD 24.02 million compared to USD 41.01 million a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.8 USD | -1.64% | -0.55% | -16.08% |
1st Jan change | Capi. | |
---|---|---|
-16.08% | 17.28M | |
+1.69% | 12.8B | |
-7.57% | 7.61B | |
+3.22% | 5.41B | |
+0.93% | 4.51B | |
+8.44% | 4.49B | |
+9.21% | 2.73B | |
-13.87% | 2.02B | |
-11.63% | 1.73B | |
+2.56% | 1.64B |
- Stock Market
- Equities
- TRIB Stock
- News Trinity Biotech plc
- Trinity Biotech plc Reports Earnings Results for the Full Year Ended December 31, 2023